First manufacturing facility to become a node in a decentralized and robust African end-to-end manufacturing network
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
BioNTech SE has taken the next step to improve vaccine supply in Africa. The company has introduced its approach to establishing scalable vaccine production by developing and delivering turnkey mRNA manufacturing facilities based on a container solution. At a high-level meeting at BioNTech's new manufacturing facility in Marburg and at the invitation of kENUP Foundation, the company presented the container solution named "BioNTainer" to its key partners.